Sheila Gujrathi
Chief Medical Officer, Receptos, Inc.
Companies
- BlossomHill Therapeutics, Inc.Board member Aug 6, 2026 to now1
- Processa Pharmaceuticals, Inc.Board member Jul 30, 2026 to now2
- Ventyx Biosciences, Inc.Board member Oct 20, 2021 to now3
- Janux Therapeutics, Inc.Board member Jun 10, 2021 to now4
- Turning Point Therapeutics, Inc.Board member Apr 16, 2019 to Jun 17, 20205
- Gossamer Bio, Inc.Board member Feb 7, 2019 to Feb 19, 20206
- Gossamer Bio, Inc.Chief executive officer Feb 7, 2019 to Feb 19, 20206
- Gossamer Bio, Inc.President Feb 7, 2019 to Feb 19, 20206
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Janux Therapeutics, Inc. JANX118,889 shares7$2.0M at $16.60Jun 11, 2025
- BlossomHill Therapeutics, Inc. BLSM90,160 shares8$1.2M at $13.62Aug 6, 2026
- Ventyx Biosciences, Inc.0 shares9Mar 4, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 4, 2026Returned to company 130,000 shares of Ventyx Biosciences, Inc.9
- Jun 11, 2025Granted 3,750 shares of Janux Therapeutics, Inc.7
- Dec 23, 2024Bought 130,000 shares at $2.31 of Ventyx Biosciences, Inc.10
- Nov 5, 2024Other 4,611 shares of Janux Therapeutics, Inc.11
- Jun 26, 2024Granted 2,500 shares of Janux Therapeutics, Inc.12
- Feb 29, 2024Other 2,986 shares of Janux Therapeutics, Inc.13
- Mar 30, 2023Sold 100,000 shares at $33.73 of Ventyx Biosciences, Inc.14
- Mar 30, 2023Exercised options 100,000 shares at $6.03 of Ventyx Biosciences, Inc.14
- Dec 21, 2022Gift 32,987 shares of Ventyx Biosciences, Inc.15
- Oct 25, 2021Converted 32,897 shares of Ventyx Biosciences, Inc.16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6SEC EDGARGossamer Bio, Inc., Board member
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Dec 26, 2024
- 11SEC EDGARForm 4 filed Nov 7, 2024
- 12SEC EDGARForm 4 filed Jun 28, 2024
- 13SEC EDGARForm 4 filed Mar 4, 2024
- 14SEC EDGARForm 4 filed Mar 31, 2023
- 15SEC EDGARForm 5 filed Feb 13, 2023
- 16SEC EDGARForm 4 filed Oct 25, 2021